Therefore, it is unsurprising that modulation of PP2A activity regulates the dephosphorylation of S112 and mediates the sensitivity of chronic lymphocytic leukaemia (CLL) cells to cAMP pathway inhibition (Moon and Lerner, 2003). Here, PTPA is linked to B-cell chronic lymphocytic leukemia.